| Bio |
2006 to present: Research Associate Professor of Neurosurgery and Neuroscience, LSUHSC, Neuroscience Center
2005 to 2006: Director of Commercial Research and Pharmacology, Inotek Pharmaceuticals Corporation
2003 - 2005: Research Associate Professor, Department of Neurology, University of Miami School of Medicine
1998 - 2003: Research Assistant Professor, Department of Neurology, University of Miami School of Medicine
1994 – 1998: Postdoctoral Research Associate, Department of Neurology, University of Miami School of Medicine
1992-1994: Neuroscientist, Department of Pharmacology, Pharmos Corp., Rehovot, Israel
1979-1990: Neurosurgeon, Department of Neurosurgery, Novosibirsk Regional Hospital, Russia,
1989: Neurovascular Fellowship-Institute of Neurosurgery N.N. Burdenko, Moscow, Russia
1991: Course of Internal Medicine, Ishilov Hospital, Tel-Aviv, Israel
CURRENT RESEARCH PROJECTS
Neuroprotection study with LAU-0901 in focal cerebral ischemia.
DHA and DHA-Albumin studies in the experimental stroke models.
Development and evaluations of Fluid Percussion Injury model in rats.
|
| Selected Publications |
L. Belayev. Mouse Intracerebral Hemorrhage Model. In: Jun Chen, Zao Xu, Xiao-Ming Xu, and John Zhang, (Eds), Animal Models of Acute Neurological Injuries, The Humana Press Inc, 349-357, 2009.
Belayev L, Khoutorova L, Atkins K, Cherqui A, Alvarez-Builla J, Bazan NG. LAU-0901, a novel platelet-activating factor receptor antagonist, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat. Brain Res, 1253, 184-190, 2009.
Belayev L, Khoutorova L, Atkins K, Gordon WC, Bazan NG. LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia. Exp. Neurol, 214, 253-258, 2008.
Belayev L, Obenaus A, Zhao W, Saul I, Busto R, Wu C, Vigdorchik A, Lin B, Ginsberg MD: Experimental intracerebral hematoma in the rat: characterization by sequential magnetic resonance imaging, behavior, and histopathology. Effect of albumin therapy, Brain Res 1157, 146-155, 2007.
Belayev L, VL Marcheselli, L. Khoutorova, EB. Rodriguez de Turco, R. Busto, MD Ginsberg, NG Bazan: Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection, Stroke 36, 118-123, 2005.
Belayev L, Khoutorova L, Zhao W, Vigdorchik A, Belayev A, Busto R, Magal E, Ginsberg MD: Neuroprotective effect of darbepoetin alfa, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats, Stroke 36, 1071-6, 2005.
Belayev L, Saul I, Busto R, Danielyan K, Vigdorchik A, Khoutorova L, Ginsberg MD: Albumin treatment reduces neurological deficit and protects blood-brain barrier integrity after acute intracortical hematoma in the rat, Stroke 36, 326-31, 2005.
Zhang Y, Belayev L, Zhao W, Irving EA, Busto R, Ginsberg MD: A selective endothelin ET(A) receptor antagonist, SB 234551, improves cerebral perfusion following permanent focal cerebral ischemia in rats, Brain Res 1045, 150-156, 2005.
Ley JJ, Vigdorchik A, Belayev L, Zhao W, Busto R, Khoutorova L, Becker DA, Ginsberg MD: Stilbazulenyl nitrone, a second-generation azulenyl nitrone antioxidant, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat: neurobehavior, histopathology, and pharmacokinetics, J Pharmacol Exp Ther 313, 1090-100, 2005.
|
